Role of Glutathione in Cancer: From Mechanisms to Therapies
Open accessThe DOI matches its Crossref record; 177 of the 179 references it cites were found in a registry or an index.
Abstract
Glutathione (GSH) is the most abundant non-protein thiol present at millimolar concentrations in mammalian tissues. As an important intracellular antioxidant, it acts as a regulator of cellular redox state protecting cells from damage caused by lipid peroxides, reactive oxygen and nitrogen species, and xenobiotics. Recent studies have highlighted the importance of GSH in key signal transduction reactions as a controller of cell differentiation, proliferation, apoptosis, ferroptosis and immune function. Molecular changes in the GSH antioxidant system and disturbances in GSH homeostasis have been implicated in tumor initiation, progression, and treatment response. Hence, GSH has both protective and pathogenic roles. Although in healthy cells it is crucial for the removal and detoxification of carcinogens, elevated GSH levels in tumor cells are associated with tumor progression and increased resistance to chemotherapeutic drugs. Recently, several novel therapies have been developed to target the GSH antioxidant system in tumors as a means for increased response and decreased drug resistance. In this comprehensive review we explore mechanisms of GSH functionalities and different therapeutic approaches that either target GSH directly, indirectly or use GSH-based prodrugs. Consideration is also given to the computational methods used to describe GSH related processes for in silico testing of treatment effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Glutathione has a number of critical roles in healthy and tumor cells, in both cases supporting cell metabolism and survival. Several glutathione functionalities are directly or indirectly regulated by oncogenes (icons based on database [50]). Refer to text for further details.](https://figures.cochat.ai/paper-figures/2d404abae89748689c9cb3c19e9fd442/role-of-glutathione-in-cancer-from-mechanisms-to-therapies-figure-4.jpg)

![Figure 6 Relative GSH and GSSG concentrations vary slightly across cancer cell lines (data presented by Li et al., [65] and obtained from https://portals.broadinstitute.org/ccle). Figure shows concentration of GSSG as a function of the concentration of GSH in the same cell line (concentrations shown in mM). Insert plot shows differences in the ratio of GSH/GSSG across 928 cell lines.](https://figures.cochat.ai/paper-figures/6fff8e4943464a249286415d7f1c507d/role-of-glutathione-in-cancer-from-mechanisms-to-therapies-figure-6.jpg)
![Figure 7 Induction of metabolic reprogramming in recipient cells by internalization of producer cell-derived exosomes. Producer cells (e.g., cancer-associated fibroblasts) contain high levels of tricarboxylic acid (TCA) cycle metabolites, amino acids and lipids that can fuel the metabolic activity of recipient tumor cells contributing to tumor progression. Producer cells (e.g., glioma cells) derived exosomes can also harbor mRNA encoding ribosomal, oxidative phosphorylation and glycolytic proteins that can reprogram glycolysis and oxidative phosphorylation in recipient cells resulting in oncogenic reprogramming and transformation. Intraexosomal cargoes, such as metabolites, amino acids and mRNA are based on the studies of Cuperlovic-Culf et al., [156] Zhao et al., [149] and Zheng et al., [150]. EV, extracellular vesicles, such as exosomes; MVB, multivesicular body; OXPHOS, oxidative phosphorylation. Refer to text for more details.](https://figures.cochat.ai/paper-figures/dc3a5462e10e4f198bbce754fbce7225/role-of-glutathione-in-cancer-from-mechanisms-to-therapies-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713 · cited 2×
“It has emerged as a central regulator of a recently discovered form of cell death known as ferroptosis which is induced by cytosolic and lipid ROS [83].”
BackgroundBiogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
Sies, H., & Jones, D. P. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0230-3 · Cited by 5,335 · cited 15×
“The itochondrial inner membrane nicotinamide nucleotide transhydrogenase (NNT) also produces NADPH and this serves to couple reductive stress-induced H2O2 production to NT-associated NADPH and glutathione redox mechanisms [17].”
BackgroundInfluentialTumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915 · cited 1×
“Chronic infection, injury and inflammation have long been recognized as risk factors for the development and progression of various human cancers [101].”
BackgroundFerroptosis: past, present and future
Li, J., Cao, F., Yin, H.-L., Huang, Z.-J., Lin, Z.-T., Mao, N., Sun, B., & Wang, G. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2298-2 · Cited by 4,171
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979 · cited 1×
“This pathway is of particular relevance to disease as oxidative stress is a hallmark of many cancers, neurodegenerative disease, and more; one result of this stress being lipid oxidation [81].”
BackgroundInflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806 · cited 2×
“A detailed review of many roles of the inflammation-driven changes in tumorigenesis has been recently provided [102].”
BackgroundMelanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579 · cited 1×
“Indeed the upregulation of NRF2 (nuclear factor, erythroid-derived 2-like 2 factor) has been observed in a wide array of tumors including breast, ovarian, prostate, skin, lung and pancreas [32,44].”
Background
Cited by
Engineering nanomedicine for glutathione depletion-augmented cancer therapy
Xiong, Y., Xiao, C., Li, Z., & Yang, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00718h · Cited by 692
Photodynamic Therapy—Current Limitations and Novel Approaches
Gunaydin, G., Gedik, M. E., & Ayan, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.691697 · Cited by 599
A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche
Zepeda-Rivera, M., Minot, S. S., Bouzek, H., Wu, H., Blanco-Míguez, A., Manghi, P., Jones, D. S., LaCourse, K. D., Wu, Y., McMahon, E. F., et al. (2024) · Nature · doi:10.1038/s41586-024-07182-w · Cited by 451
“GSH deficiency or an elevated ratio of oxidized (GSSG) to reduced (GSH) forms of glutathione increases the vulnerability of mammalian cells to oxidative stress, inflammation and tumour progression 55 .”
BackgroundLipid Peroxidation and Antioxidant Protection
Valgimigli, L. (2023) · Biomolecules · doi:10.3390/biom13091291 · Cited by 335
“Therefore, compared to healthy non-malignant cells, cancer cells have altered redox homeostasis and higher levels of LP; in many types of tumor cells, these higher levels support their growth, proliferation and survival [81].”
Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy
Li, H., Kim, Y., Jung, H., Hyun, J. Y., & Shin, I. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00722c · Cited by 356
Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics
Wei, D., Sun, Y., Zhu, H., & Fu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.3c06019 · Cited by 303
The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy
Han, H.-H., Wang, H.-M., Jangili, P., Li, M., Wu, L., Zang, Y., Sedgwick, A. C., Li, J., He, X.-P., James, T. D., et al. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00673a · Cited by 299
Ferroptosis in the tumor microenvironment: perspectives for immunotherapy
Xu, H., Ye, D., Ren, M., Zhang, H., & Bi, F. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.06.014 · Cited by 294
Weaver, K., & Skouta, R. (2022) · Biomedicines · doi:10.3390/biomedicines10040891 · Cited by 266
Harnessing Nanomaterials for Cancer Sonodynamic Immunotherapy
Liang, S., Yao, J., Liu, D., Rao, L., Chen, X., & Wang, Z. (2023) · Advanced Materials · doi:10.1002/adma.202211130 · Cited by 243
Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review
Kong, C., & Chen, X. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s388996 · Cited by 209
Current Advances in Stimuli-Responsive Hydrogels as Smart Drug Delivery Carriers
Zhang, Y., & Wu, B. M. (2023) · Gels · doi:10.3390/gels9100838 · Cited by 192
“Furthermore, a majority of tumors exhibit elevated GSH levels, which contribute substantially to tumorigenesis and inflammation responses within the tumor microenvironment [144].”
BackgroundThe pleiotropic functions of reactive oxygen species in cancer
Wu, K., El Zowalaty, A. E., Sayin, V. I., & Papagiannakopoulos, T. (2024) · Nature Cancer · doi:10.1038/s43018-024-00738-9 · Cited by 196
“Last, SRX functions to both regenerate PRDX by reducing overoxidized sulfinic acid cysteines and regulating glutathionylation in response to oxidative stress 43 .”
InfluentialSmart molecular designs and applications of activatable organic photosensitizers
Nestoros, E., Sharma, A. K., Kim, E., Kim, J. S., & Vendrell, M. (2024) · Nature Reviews Chemistry · doi:10.1038/s41570-024-00662-7 · Cited by 202
Impact of cancer metabolism on therapy resistance – Clinical implications
Gonçalves, A. C., Richiardone, E., Jorge, J., Polónia, B., Xavier, C. P. R., Salaroglio, I. C., Riganti, C., Vasconcelos, M. H., Corbet, C., & Sarmento-Ribeiro, A. B. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100797 · Cited by 164
Potential of Copper and Copper Compounds for Anticancer Applications
Ji, P., Wang, P., Chen, H., Xu, Y., Ge, J., Tian, Z., & Yan, Z. (2023) · Pharmaceuticals · doi:10.3390/ph16020234 · Cited by 162
“Tumor cells metabolize glucose mainly through the glycolytic pathway for normal growth and reproduction, and cells undergoing glycolysis are less susceptible to cuproptosis than cells undergoing mitochondrial respiration; in addition, intracellular glutathione (GSH) can act as a copper chelator to inhibit cellular cup…”
BackgroundChen, X., Argandona, S. M., Melle, F., Rampal, N., & Fairen‐Jiménez, D. (2023) · Chem · doi:10.1016/j.chempr.2023.09.016 · Cited by 189
Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development
Yu, W., Tu, Y., Long, Z., Liu, J., Kong, D., Peng, J., Wu, H., Zheng, G., Zhao, J., Chen, Y., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2606928 · Cited by 161
“Inhibition of GPX1 activity and GSH synthesis are also associated with reduced proliferative capacity in various tumor cells [120, 121].”
Hybrid Biomimetic Membrane Coated Particles-Mediated Bacterial Ferroptosis for Acute MRSA Pneumonia
Hu, H., Hua, S. Y., Lin, X., Lu, F., Zhang, W., Zhou, L., Cui, J., Wang, R., Xia, J., Xu, F., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c02365 · Cited by 156
Ferritinophagy and ferroptosis in cardiovascular disease: Mechanisms and potential applications
Qin, Y., Qiao, Y., Wang, D., Tang, C., & Yan, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111872 · Cited by 159
TFRC upregulation promotes ferroptosis in CVB3 infection via nucleus recruitment of Sp1
Lu, Y., Hu, Y., Wu, Z., Li, Y., Kong, M., Kang, Z., Zuoyuan, B., & Yang, Z. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05027-w · Cited by 143
“GSH acts as a regulator of cellular redox state to protect cells from damage caused by lipid peroxides, reactive oxygen and xenobiotics [33].”
BackgroundBiomedical applications of MnO2 nanomaterials as nanozyme-based theranostics
Sisakhtnezhad, S., Rahimi, M., & Mohammadi, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114833 · Cited by 136
Potęga, A. (2022) · Molecules · doi:10.3390/molecules27165252 · Cited by 133
Zheng, X., Jin, X., Ye, F., Liu, X., Yu, B., Li, Z., Zhao, T., Chen, W., Liu, X., Di, C., et al. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00427-w · Cited by 134
“GSH acts as a free radical scavenger and a cofactor of GPX4 to alleviate oxidative stress and maintain redox homeostasis [37, 38].”
BackgroundLi, K., Xu, K., He, Y., Yang, Y., Tan, M., Mao, Y., Zou, Y., Feng, Q., Luo, Z. Y., & Cai, K. (2023) · ACS Nano · doi:10.1021/acsnano.2c10893 · Cited by 124
Junnuthula, V., Kolimi, P., Nyavanandi, D., Sampathi, S., Vora, L. K., & Dyawanapelly, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091860 · Cited by 126
“The GSH concentration is higher in the cytoplasm of cells in comparison to plasma, and its concentration is four-fold greater in tumor tissues than in normal tissues [63].”
BackgroundStimulus-Controlled Anion Binding and Transport by Synthetic Receptors
de Jong, J., Bos, J. E., & Wezenberg, S. J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00039 · Cited by 113
Interplay of oxidative stress and antioxidant mechanisms in cancer development and progression
Jomová, K., Alomar, S. Y., Valko, R., Fresser, L., Nepovimová, E., Kuča, K., & Valko, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04146-5 · Cited by 130
“GSH has been found to be increased in various cancer cells (Kennedy et al. 2020).”
Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A., Marinari, U. M., Domenicotti, C., & Traverso, N. (2022) · Antioxidants · doi:10.3390/antiox11081613 · Cited by 111
“In particular, it has been found that GPX1 and GPX2 modulate proinflammatory mediator synthesis and release, and their up-regulation is critically involved in the development and promotion of colorectal cancer and [226].”
BackgroundEmerging Chemodynamic Nanotherapeutics for Cancer Treatment
Sun, D., Sun, X., Zhang, X., Wu, J., Shi, X., Sun, J., Luo, C., He, Z., & Zhang, S. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400809 · Cited by 104
Nanocatalysts for modulating antitumor immunity: fabrication, mechanisms and applications
Wu, X., Li, Y., Wen, M., Xie, Y., Zeng, K., Liu, Y., Chen, W., & Zhao, Y. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00673e · Cited by 101
Jain, R., Hussein, M. A., Pierce, S., Martens, C., Shahagadkar, P., & Munirathinam, G. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106138 · Cited by 106
“More recently, numerous innovative drugs have been studied to target the GSH antioxidant system [53,54].”
Natural Compounds and Glutathione: Beyond Mere Antioxidants
Giacomo, C. D., Malfa, G. A., Tomasello, B., Bianchi, S., & Acquaviva, R. (2023) · Antioxidants · doi:10.3390/antiox12071445 · Cited by 97
GSH and Ferroptosis: Side-by-Side Partners in the Fight against Tumors
Jiang, Y., Glandorff, C., & Sun, M. (2024) · Antioxidants · doi:10.3390/antiox13060697 · Cited by 99
DNA Logic Circuits for Cancer Theranostics
Chen, J., Fu, S., Zhang, C., Liu, H., & Su, X. (2022) · Small · doi:10.1002/smll.202108008 · Cited by 98
Cuevas-Cianca, S. I., Romero-Castillo, C., Gálvez-Romero, J. L., Juárez, Z. N., & Hernández, L. R. (2023) · Molecules · doi:10.3390/molecules28031488 · Cited by 99
“N2-type TAN enhances angiogenesis, tumor growth, invasion, and metastasis, whereas N1-type TAN promotes phagocytosis, the presence of reactive oxygen species (ROS), and apoptosis [33–35].”
BackgroundInfluentialNanomaterial-based regulation of redox metabolism for enhancing cancer therapy
Jia, X., Wang, Y., Qiao, Y., Jiang, X., & Li, J. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00404c · Cited by 91
F2F: Reliable storage in open networks
Li, J., & Dabek, F. (2006) · International Workshop on Peer-to-Peer Systems · Cited by 84
An Update on Glutathione's Biosynthesis, Metabolism, Functions, and Medicinal Purposes
Gasmi, A., Nasreen, A., Lenchyk, L. V., Lysiuk, R., Peana, M., Shapovalova, N., Piscopo, S., Komisarenko, M. A., Shanaida, M., Smetanina, K., et al. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673251025230919105818 · Cited by 93
The Cancer Antioxidant Regulation System in Therapeutic Resistance
Gu, X., Mu, C., Zheng, R., Zhang, Z., Zhang, Q., & Liang, T. (2024) · Antioxidants · doi:10.3390/antiox13070778 · Cited by 92
“While GPX3 is an extra-cellular lipid peroxidase, GPX4 is the most important intracellular enzyme for detoxifying lipid hydroperoxides, and together with ferroptosis suppressor protein 1 (FSP1), GPX4 and FSP1 constitute two key proteins involved in the defense against ferroptosis [123,164,165].”
BackgroundMesoporous silica/organosilica nanoparticles for cancer immunotherapy
Theivendran, S., Lazarev, S., & Yu, C. (2023) · Exploration · doi:10.1002/exp.20220086 · Cited by 83
Glutathione-Dependent Pathways in Cancer Cells
Kalinina, E. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158423 · Cited by 88
“Changes in the levels of GSH have been observed in various human cancers, and elevated GSH levels in cancer cells are associated with tumor progression and increased resistance to chemotherapeutic drugs [4].”
BackgroundRiluzole: A neuroprotective drug with potential as a novel anti‑cancer agent (Review)
Blyufer, A., Lhamo, S., Tam, C., Tariq, I., Thavornwatanayong, T., & Mahajan, S. S. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5275 · Cited by 87
Wang, K., Zhang, Y., Mao, W., Feng, W., Lu, S., Wan, J., Song, X., Chen, Y., & Peng, B. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202109221 · Cited by 77
A comprehensive review on medicinal plants possessing antioxidant potential
Zafar, F., Asif, H. M., Shaheen, G., Ghauri, A. O., Rajpoot, S. R., Tasleem, M. W., Shamim, T., Hadi, F., Noor, R., Ali, T., et al. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13743 · Cited by 91
“GSH-Px has a direct role in scavenging ROS and xenobiotic substances metabolism.(14) Metal binding proteins are capable of scavenging free iron and copper ions that can catalyse oxidation reactions.”
BackgroundFu, R., Zhao, B., Chen, M., Fu, X., Zhang, Q., Cui, Y., Hu, X., & Zhou, W. (2023) · Medical Oncology · doi:10.1007/s12032-023-02237-w · Cited by 77
“For instance, glutathione peroxidases (GPXs) utilize GSH to reduce hydrogen peroxide and lipid hydroperoxides, transforming them into alcohols and water [16].”
BackgroundYu, L., Huang, K., Liao, Y., Wang, L., Sethi, G., & Ma, Z. (2024) · Cell Proliferation · doi:10.1111/cpr.13644 · Cited by 79
“54 Ferropto-sis has been implicated in various diseases and functions as a mechanism for suppressing tumours.”
BackgroundUti, D. E., Atangwho, I. J., Alum, E. U., Ntaobeten, E., Obeten, U. N., Bawa, I., Agada, S. A., Ukam, C. I.-O., & Egbung, G. E. (2025) · Discover Nano · doi:10.1186/s11671-025-04248-0 · Cited by 81
Bonet‐Aleta, J., Sancho‐Albero, M., Calzada-Funes, J., Irusta, S., Martín‐Duque, P., Hueso, J. L., & Santamaría, J. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.03.036 · Cited by 76
Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death
Banstola, A., Poudel, K., Kim, J. O., Jeong, J., & Yook, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.038 · Cited by 73
Albumin-hitchhiking: Fostering the pharmacokinetics and anticancer therapeutics
Famta, P., Shah, S., Jain, N., Srinivasarao, D. A., Murthy, A., Ahmed, T., Vambhurkar, G., Shahrukh, S., Singh, S. B., & Srivastava, S. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.034 · Cited by 68
Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production
Bel’skaya, L. V., & Dyachenko, E. I. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050282 · Cited by 81
“The vulnerability of cancer cells to oxidative stress increases with GSH deficiency, or the GSH/GSSG ratio decreases [93].”
BackgroundAlbumin-Based Nanoparticles for the Delivery of Doxorubicin in Breast Cancer
Prajapati, R., García-Garrido, E., & Somoza, Á. (2021) · Cancers · doi:10.3390/cancers13123011 · Cited by 70
Metabolism of Selenium, Selenocysteine, and Selenoproteins in Ferroptosis in Solid Tumor Cancers
Shimada, B. K., Swanson, S. M., Toh, P., & Seale, L. A. (2022) · Biomolecules · doi:10.3390/biom12111581 · Cited by 71
“Depending on the mutations present in the cancer cell, the heterogeneous tumor can either have cells downregulating or upregulating one of the GPXs, with cellular impacts on metabolic pathways of glucose [86], GSH [82], and lipid metabolism [87].”
BackgroundInnovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance
Meng, W., Huang, L., Guo, J., Xin, Q., Liu, J., & Hu, Y. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121549 · Cited by 78
“Tumor cells, especially in hypoxic regions, usually have high levels of reducing molecules such as GSH [63], and these nanoparticles are able to degrade rapidly upon encountering GSH, thereby re-leasing the drug and enhancing tumor killing [64].”
Biotin-functionalized nanoparticles: an overview of recent trends in cancer detection
Fathi‐karkan, S., Sargazi, S., Shojaei, S., Far, B. F., Mirinejad, S., Cordani, M., Khosravi, A., Zarrabi, A., & Ghavami, S. (2024) · Nanoscale · doi:10.1039/d4nr00634h · Cited by 66
Huang, W., Wen, F., Yang, P., Ye, L., Li, Q., & Shu, P. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155220 · Cited by 72
Al-Temimi, A. A., AL-Mossawi, A.-E.-B. H. J., Al-Hilifi, S. A., Korma, S. A., Esatbeyoglu, T., Rocha, J. M., & Agarwal, V. (2023) · Metabolites · doi:10.3390/metabo13040465 · Cited by 64
“[15], and readers interested in this topic are directed to that comprehensive review.”
BackgroundMethodInfluentialIchihara, G., Katsumata, Y., Sugiura, Y., Matsuoka, Y., Maeda, R., Endo, J., Anzai, A., Shirakawa, K., Moriyama, H., Kitakata, H., et al. (2023) · Circulation Research · doi:10.1161/circresaha.123.323517 · Cited by 66
“50 However, studies on extracellular glutathione transport in the heart remain limited.”
BackgroundTumor microenvironment responsive nanozymes for multimodal imaging of tumors
Wang, H., Ouyang, W., & Liu, H. (2024) · Nano TransMed · doi:10.1016/j.ntm.2024.100032 · Cited by 67
Zhao, C., Zhang, T., Xue, S.-T., Zhang, P., Wang, F., Li, Y., Liu, Y., Zhao, L., Wu, J., Yan, Y., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.09.013 · Cited by 65
Nanoparticle-integrated hydrogels as versatile colorimetric sensors
Song, H., Jung, D. H., Cho, Y., Cho, H. H., Panferov, V. G., Liu, J., Heo, J. H., & Lee, J. H. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216835 · Cited by 61
Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer
Cai, H.-J., Zhuang, Z.-C., Wu, Y., Zhang, Y., Liu, X., Zhuang, J., Yang, Y.-F., Gao, Y., Chen, B., & Guan, G. (2021) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2020.5617 · Cited by 72
“Indeed, glutathione participated in antioxidant defences intracellularly, and inhibition of glutathione synthesis is a crucial step of ferroptosis[32, 33].”
BackgroundRoy, N., & Paira, P. (2024) · ACS Omega · doi:10.1021/acsomega.3c08890 · Cited by 63
Redox-Responsive Mesoporous Silica Nanoparticles for Cancer Treatment: Recent Updates
Gisbert-Garzarán, M., & Vallet‐Regí, M. (2021) · Nanomaterials · doi:10.3390/nano11092222 · Cited by 59
“Of note, most tumoral cells have a higher ROS set point than that of associated healthy cells, which may contribute to tumor growth, proliferation, and metastasis [10,11].”
Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Sharma, N. K., Bahot, A., Sekar, G., Bansode, M., Khunteta, K., Sonar, P. V., Hebale, A., Salokhe, V., & Sinha, B. K. (2024) · Cancers · doi:10.3390/cancers16040680 · Cited by 65
“The intricate involvement of GSH extends across various cellular processes, encompassing cell differentiation, ferroptosis, apoptosis, proliferation, and anticancer responsiveness [19].”
BackgroundZhang, S., Huang, Q., Ji, T., Li, Q., & Hu, C. (2024) · Biomarker Research · doi:10.1186/s40364-024-00677-8 · Cited by 60
“Meanwhile, elevated levels of GSH, DLAT, ATP7A, and ATP7B were correlated with increased resistance to chemotherapeutic drugs [54, 60, 61, 96], furthermore, CuET could bypass GSH interference and reverse cisplatin resistance through cuproptosis effects [149].”
BackgroundMetabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment
Aden, D., Sureka, N., Zaheer, S., Chaurasia, J. K., & Zaheer, S. (2024) · Immunology · doi:10.1111/imm.13871 · Cited by 66
“Cancer cells are often under increased oxidative stress, and glutathione plays a role in mitigating this damage and promoting survival [91].”
Gote, V., Sharma, A. D., & Pal, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031257 · Cited by 57
Lipid Catabolism and ROS in Cancer: A Bidirectional Liaison
Castelli, S., Falco, P. D., Ciccarone, F., Desideri, E., & Ciriolo, M. R. (2021) · Cancers · doi:10.3390/cancers13215484 · Cited by 63
“Indeed, an elevated GSH level is a marker of tumor aggressiveness and drug resistance [142].”
BackgroundProdrug-conjugated tumor-seeking commensals for targeted cancer therapy
Shen, H., Zhang, C., Li, S., Liang, Y., Lee, L. T., Aggarwal, N., Wun, K. S., Liu, J., Nadarajan, S. P., Weng, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48661-y · Cited by 69
“10, 11, all four NPCs express heparan sulfate proteoglycans (HSPG) syndecan-1 and syndecan-2 which are absent in HNC cells.”
Schiff bases and their metal complexes to target and overcome (multidrug) resistance in cancer
Podolski-Renić, A., Gašparović, A. Č., Valente, A., López, Ó., Nunes, J. H. B., Kowol, C. R., Heffeter, P., & Filipović, N. R. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116363 · Cited by 65
Glutathione‐triggered prodrugs: Design strategies, potential applications, and perspectives
Zhao, J., Li, X., Ma, T., Chang, B., Zhang, B., & Fang, J. (2023) · Medicinal Research Reviews · doi:10.1002/med.22007 · Cited by 55
“A (Figure 17B) that exhibit dual ‐ responsiveness to pH and GSH. 165 Under GST catalysis, GSH is capable of efficiently enhancing the fluorescence intensity of both prodrug molecules, and HPLC analysis demonstrated successful release of the active payload from prodrug 33 .”
BackgroundInfluentialJeandet, P., Sobarzo‐Sánchez, E., Uddin, M. S., Bru‐Martínez, R., Clément, C., Jacquard, C., Nabavi, S. F., Khayatkashani, M., Batiha, G. E., Khan, H. Z., et al. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107844 · Cited by 59
Glutathione: Lights and Shadows in Cancer Patients
Marini, H. R., Facchini, B. A., Francia, R. D., Freni, J., Puzzolo, D., Montella, L., Facchini, G., Ottaiano, A., Berretta, M., & Minutoli, L. (2023) · Biomedicines · doi:10.3390/biomedicines11082226 · Cited by 55
Chen, J., Zaal, E. A., Berkers, C. R., Ruijtenbeek, R., Garssen, J., & Redegeld, F. A. (2021) · Cells · doi:10.3390/cells10092287 · Cited by 52
“Glutathione (GSH) is a tripeptide consisting of glutamate, cysteine, and glycine that functions to maintain cellular redox homeostasis [48].”
BackgroundFeng, S., Zhou, Y., Huang, H., Lin, Y. C., Zeng, Y., Han, S., Huang, K., Liu, Q., Zhu, W., Yuan, Z., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.865073 · Cited by 52
“While GSH is an important antioxidant and a free radical scavenger (Kennedy et al., 2020), GPX4 can specifically catalyse the conversion of lipid peroxides into lipid alcohols through the oxidation of GSH.”
BackgroundRecent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy
Li, X., Geng, X., Chen, Z., & Yuan, Z. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106218 · Cited by 52
Sagadevan, S., & Oh, W. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104569 · Cited by 53
Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy
Yang, R., Chen, L., Wang, Y., Zhang, L., Zheng, X., Yang, Y., & Zhu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1237361 · Cited by 50
Peptide-based nanomaterials and their diverse applications
Das, T. N., Ramesh, A., Ghosh, A. P., Moyra, S., Maji, T. K., & Ghosh, G. (2024) · Nanoscale Horizons · doi:10.1039/d4nh00371c · Cited by 51
Lu, S., Feng, W., Yao, X., Song, X., Guo, J., Chen, Y., & Hu, Z. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121688 · Cited by 49
SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer
Kim, M., Kim, H. S., Kang, H. W., Lee, D. E., Hong, W. C., Kim, J.-H., Kim, M., Cheong, J., Kim, H. J., & Park, J. S. (2023) · Cells · doi:10.3390/cells12202509 · Cited by 49
Glutamine transporter SLC38A3 promotes breast cancer metastasis via Gsk3β/β-catenin/EMT pathway
Tan, Z., Boyapati, K., Tressler, C. M., Jenkinson, N. M., & Glunde, K. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216653 · Cited by 48
The Redox Paradox: Cancer’s Double-Edged Sword for Malignancy and Therapy
Ranbhise, J. S., Singh, M. K., Ju, S., Han, S., Yun, H. R., Kim, S. S., & Kang, I. (2025) · Antioxidants · doi:10.3390/antiox14101187 · Cited by 50
“In which the three precursor amino acids, namely L-glutamate, cysteine, and glycine, are combined to form the tripeptide GSH [60].”
DNA nanostructures for stimuli-responsive drug delivery
Wang, T., Liu, Y., Wu, Q., Lou, B., & Liu, Z. (2021) · Smart Materials in Medicine · doi:10.1016/j.smaim.2021.12.003 · Cited by 46
Glutamine metabolism in cancers: Targeting the oxidative homeostasis
Gong, T., Zheng, C., Ou, X., Zheng, J., Yu, J., Chen, S., Duan, Y., & Liu, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.994672 · Cited by 40
Zhou, Z., Li, X., Yang, G., Wang, J., Li, B., Huang, Y., Yan, J., & Tao, K. (2023) · Theranostics · doi:10.7150/thno.83377 · Cited by 47
“Glutathione (GSH) could trigger the release of thiols from the surface of AuNPs, and intracellular GSH concentration has been reported to be in the millimolar level, whereas extracellular GSH was found only in the micromolar range [44].”
Trejo‐Solís, C., Silva‐Adaya, D., Serrano-García, N., Magaña-Maldonado, R., Jiménez‐Farfán, D., Ferreira-Guerrero, E., Cruz-Salgado, A., & Castillo‐Rodríguez, R. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417633 · Cited by 50
“The expression of NRF2 was significantly higher in glioma tissues than in normal brain tissues [274] and Interestingly PI3K/AKT axis is also shown to produce GSH by nuclear factor erythroid 2–related factor 2 (NRF2) stabilization [275,276].”
BackgroundTalib, W. H., Baban, M. M., Azzam, A. O., Issa, J. J., Ali, A. Y., AlSuwais, A. K., Allala, S., & Kury, L. T. A. (2024) · Molecules · doi:10.3390/molecules29061320 · Cited by 56
“GSH is present throughout cellular compartments at millimolar quantities and contributes to the maintenance of healthy levels of intracellular oxidative equilibrium, serving as an antioxidant and driving metabolism [97].”
BackgroundTamang, J. P., Das, S., Kharnaior, P., Pariyar, P., Thapa, N., Jo, S.-W., Yim, E.-J., & Shin, D.-H. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110904 · Cited by 49
Glutathione and glutathione disulfide – their biomedical and pharmaceutical applications
Guan, X. (2023) · Medicinal Chemistry Research · doi:10.1007/s00044-023-03116-9 · Cited by 49
Hoskinson, C., Zheng, K., Gabel, J., Kump, A., German, R., Podicheti, R., Marino, N., & Stiemsma, L. T. (2022) · mSystems · doi:10.1128/msystems.01489-21 · Cited by 53
“GSH metabolism plays a critical role in cancer initiation, as it mediates the removal and detoxification of carcinogens (19).”
Hsiao, Y., Mukundan, A., Chen, W., Wu, M., Hsieh, S.-C., & Wang, H. (2022) · Biosensors · doi:10.3390/bios12060405 · Cited by 44
“The relative amount GSH and glutathione disulfide (GSSG) will differ between cancer lines [60].”
BackgroundBiomarker‐Responsive Nanosystems for Chronic Disease Theranostics
Fu, Q., Yu, L., Wang, Y., Li, P., & Song, J. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202206300 · Cited by 45
Mechanism and role of regulated cell death in tumor immunity and immunotherapy
Hu, J., Li, Y., Lian, B., Mao, Y., & Zhao, L. (2025) · 癌症:英文版 · doi:10.1002/cac2.70064 · Cited by 45
“As a novel RCD distinct in morphology, biochemistry, and genetics [26], ferroptosis involves three core pathways: the iron metabolism pathway [27], lipid oxidation pathway [28], and glutathione metabolism pathway [29].”
Scuto, M. C., Salinaro, A. T., Caligiuri, I., Ontario, M. L., Greco, V., Sciuto, N., Crea, R., Calabrese, E. J., Rizzolio, F., Canzonieri, V., et al. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111551 · Cited by 49
Adinew, G. M., Messeha, S. S., Taka, E., Badisa, R. B., & Soliman, K. F. A. (2022) · Nutrients · doi:10.3390/nu14224787 · Cited by 42
“Previous studies have shown that glutathione metabolism can affect cancer in beneficial and detrimental ways [61,62].”
BackgroundOrientin: a comprehensive review of a promising bioactive flavonoid
Fahmy, M. I., Sadek, M. A., Abdou, K., El‐Dessouki, A. M., El‐Shiekh, R. A., & Khalaf, S. S. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01690-5 · Cited by 45
“These influences not only because of its antioxidant properties, but also due to its ability to modify cell growth, immunity, and programmed cellular death (Kennedy et al. 2020).”
Radical recombination and antioxidants: a hypothesis on the FLASH effect mechanism
Hu, A., Qiu, R., Li, W. B., Zhou, W., Wu, Z., Zhang, H., & Li, J. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2110307 · Cited by 43
“…of antioxidants than that in normal tissue and the oxygen level of tumors is lower than that of normal tissue, which has been studied as the target of drug delivery and the indicator of tumor imaging (Gamcsik et al. 2012; Traverso et al. 2013; Guo et al. 2019; Kennedy et al. 2020; Li et al. 2020).”
Background
Metadata
- Authors
- Kennedy, L., Sandhu, J. K., Harper, M.-E., & Cuperlovic-Culf, M.
- Affiliations
- University of Ottawa (CA)
- Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 451 Smyth Road, Ottawa, ON K1H 8M5, Canada
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-10-09
- Volume
- 10
- Issue
- 10
- Pages
- 1429
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC7600400
- OpenAlex
- W3092136373
- Cited by
- 880
- References
- 179
- Citations by year
- 2026: 140 · 2025: 197 · 2024: 201 · 2023: 159 · 2022: 123 · 2021: 58
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- NPARC (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Council Canada
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- glutathione, cancer, redox homeostasis, antioxidant defense, reactive oxygen species, reactive nitrogen species, lipid peroxidation, xenobiotic detoxification, chemoresistance, ferroptosis, apoptosis, tumor progression
- MeSH terms
- Animals, Drug Screening Assays, Antitumor, Glutathione, Homeostasis, Humans, Neoplasms, Oxidation-Reduction, Signal Transduction, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.